Articles From: CECO Environmental Reports First Quarter 2013 Results to Idera Announces Presentation of Positive Data from Phase 2 Trial of TLR 7 and 9 Antagonist in Patients with Moderate-to-Severe Plaque Psoriasis


2013/5/8
Continued Increases in Margins, Bookings and Earnings per Share CINCINNATI , May 8, 2013 /PRNewswire/ --  CECO Environmental Corp.
Sign-up for CECO Environmental Reports First Quarter 2013 Results investment picks
2013/5/8
http://media.marketwire.com/attachments/201103/22521_KS_Logo_Color_R_2011.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1014712&ProfileId=051205&sourceType=1 TROY, MI --
Sign-up for Kelly Services(R) Reports 1st Quarter Results investment picks
2013/5/8
http://media.marketwire.com/attachments/201305/60865_solarw.jpg http://media.marketwire.com/attachments/201305/TN-152461_Thwack_Logo.jpg SolarWinds' online IT management community, thwack, serves as the go-to resource for IT professionals, delivering unmatched value to more than 125,000 members, providing industry insight, camaraderie, questions and answers, and more.
Sign-up for IT Professional Community thwack Helps Crowdsource 43 New SolarWinds Product Features investment picks
2013/5/8
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1014291&ProfileId=051205&sourceType=1 HAMILTON, BERMUDA --
Sign-up for Notice of Announcement First Quarter Results investment picks
2013/5/8
DANBURY, Conn., May 8, 2013 (GLOBE NEWSWIRE) -- Biodel Inc. (Nasdaq:BIOD) today reported financial results for the second fiscal quarter ended March 31, 2013.
Sign-up for Biodel Reports Second Quarter Fiscal Year 2013 Financial Results investment picks
2013/5/8
Verastem, Inc., (NASDAQ: VSTM) focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced that members of the management team will be presenting at several upcoming conferences.
Sign-up for Verastem to Present at Upcoming Conferences investment picks
2013/5/8
THE WOODLANDS, Texas , May 8, 2013 /PRNewswire/ -- TETRA Technologies, Inc. (TETRA or the Company) (NYSE: TTI) today announced first quarter 2013 net income from continuing operations attributable to TETRA stockholders of $0.02 per fully diluted share compared to $0.01 per fully diluted share reported in the first quarter of 2012.
Sign-up for TETRA Technologies, Inc. Announces First Quarter 2013 Results investment picks
2013/5/8
HOUSTON , May 8, 2013 /PRNewswire/ -- Consolidated Graphics, Inc. (NYSE: CGX) today announced that it will hold a conference call on Wednesday, May 15, 2013 to discuss the Company's results for its fiscal fourth quarter and year ended March 31, 2013 .
Sign-up for Consolidated Graphics Will Hold a Conference Call to Discuss the Company's Fourth Quarter and Full Year 2013 Financial Results investment picks
2013/5/8
Liberty Interactive Corporation (“Liberty”) (Nasdaq: LINTA, LINTB, LVNTA, LVNTB) today reported first quarter 2013 results.
Sign-up for Liberty Interactive Corporation Reports First Quarter 2013 Financial Results investment picks
2013/5/8
ISELIN, N.J. , May 8, 2013 /PRNewswire/ -- Maidenform Brands, Inc. (NYSE: MFB) , a global intimate apparel company, today reported first quarter 2013 net sales of $131.2 million and a loss per share of $(0.05) .
Sign-up for Maidenform Brands, Inc. Reports First Quarter 2013 Results and Confirms Guidance for Full Year 2013 investment picks
2013/5/8
http://media.marketwire.com/attachments/201305/TN-152711_X26PBlack3QDrama.jpg The TASER(R) X26P(TM) conducted energy weapon (CEW) with dual shot capability.
Sign-up for Kansas Highway Patrol Deploys 386 TASER Smart Weapons investment picks
2013/5/8
USA Technologies, Inc. (NASDAQ: USAT) , (“USAT”) a leader of wireless, cashless payment and M2M telemetry solutions for small-ticket, self-serve retailing industries, today released data from its 2013 Cashless Knowledge Base that demonstrates how a cashless payment platform can be instrumental in driving additional revenues.
Sign-up for New Data from USA Technologies’ 2013 Cashless Knowledge Base Tracks Positive Impact on Sales for Machines Enabled by Its Cashless Payment Platform investment picks
2013/5/8
The GEO Group, Inc. (NYSE:GEO) (“GEO”), the world’s leading provider of diversified correctional, detention, and community reentry services, announced today that it has established an “at-the-market” equity offering program through which it may from time to time sell shares of its common stock for an aggregate offering price of up to $100 million.
Sign-up for The GEO Group Establishes at the Market Equity Offering Program investment picks
2013/5/8
The GEO Group, Inc. (NYSE: GEO) ("GEO") announced that on May 7, 2013, its Board of Directors declared a quarterly cash dividend of $0.50 per share which will be paid on June 3, 2013 to shareholders of record as of the close of business on May 20, 2013.
Sign-up for The GEO Group Declares Quarterly Cash Dividend of $0.50 Per Share investment picks
2013/5/8
The GEO Group, Inc. (NYSE: GEO) (“GEO”), the world’s leading provider of diversified correctional, detention, and community reentry services, reported today its financial results for the first quarter 2013.
Sign-up for The GEO Group Reports First Quarter 2013 Results investment picks
2013/5/8
The Coca-Cola Company today announces four global business commitments to further contribute to healthier, happier, and more active communities.
Sign-up for Coca-Cola Announces Global Commitments to Help Fight Obesity investment picks
2013/5/8
Kopin Corporation (NASDAQ: KOPN) , a leading provider of critical components and licensed concept systems to partners who develop branded wearable computing products, today announced financial results for the first quarter ended March 30, 2013.
Sign-up for Kopin Corporation Reports First-Quarter 2013 Financial Results investment picks
2013/5/8
KELOWNA, BC , May 7, 2013 /PRNewswire/ - Appiphany Technologies Holdings Corp.
Sign-up for Appiphany Technologies enters into agreement with independent film producer to develop cartoon series investment picks
2013/5/8
FORE-SIGHT ® Sales Increase 31% BRANFORD, Conn., May 8, 2013 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today reported financial results for the three months ended March 31, 2013.
Sign-up for CASMED Announces First Quarter 2013 Financial Results investment picks
2013/5/8
FORT LAUDERDALE, Fla.
Sign-up for iTalk Establishes Asian Operations Office and Names Philip Loh as Director of Asia Operations investment picks
2013/5/8
BEIJING , May 8, 2013 /PRNewswire/ -- The board of directors (the "Board") of China Life Insurance Company Limited (the "Company") (NYSE: LFC; HKSE: 2628; SSE: 601628) announced today that on March 27, 2013 , the Board approved the appointment of Mr.
Sign-up for China Life Announces the Appointment of Mr. Yang Zheng as Chief Financial Officer investment picks
2013/5/8
LONDON --
Sign-up for Tullow CEO Sees Uganda Oil Plan MOU Agreed in Next Few Weeks investment picks
2013/5/8
DaVita HealthCare Partners Inc. (DVA) moved to resolve two lingering uncertainties Tuesday, reaching an agreement to constrain Warren Buffett's Berkshire Hathaway Inc. (BRK.A, BRK.B) from engineering a takeover of the firm, and setting aside $300 million to settle a U.S. Justice Department investigation into a potential kickback scheme.
Sign-up for DaVita HealthCare, Berkshire Agree to Standstill Agreement investment picks
2013/5/8
Network equipment joint venture Nokia Siemens Networks (NOK, SI) said Wednesday that Rick Corker, head of the North American region, will join the company's executive board and executive management team, effective immediately.
Sign-up for Nokia Siemens: N Amer Head Rick Corker To Join Executive Board investment picks
2013/5/8
NEW YORK (MarketWatch) - AOL Inc. AOL reported its first-quarter profit rose 23% to $25.9 million, or 32 cents a share, from $21.1 million, or 22 cents a share, a year earlier.
Sign-up for PULSE: AOL Q1 profit rises on advertising growth investment picks
2013/5/8
BURLINGTON, Mass., May 8, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO) , a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer, announced today its financial results for the first quarter ended March 31, 2013.
Sign-up for Coronado Biosciences Reports Financial Results for the First Quarter Ended March 31, 2013 investment picks
2013/5/8
LONDON --Strong demand for technology used to stream music from smartphones to wireless speakers helped chip designer CSR PLC (CSR.LN) beat revenue expectations for the first quarter.
Sign-up for Wireless Music Streaming Demand Boosts CSR's 1Q Revenue investment picks
2013/5/8
Revenues were $1.56 billion for the first quarter of 2013 Segment operating margin was 7.7 percent, a 124 bps improvement over Q1 2012 Total operating margin was 6.1 percent, up from 5.1 percent in the same period last year Diluted earnings per share was $0.87 for the quarter Cash and cash equivalents at the end of the quarter were $652 million NEWPORT NEWS, Va., May 8, 2013 (GLOBE NEWSWIRE) -- Huntington Ingalls Industries (NYSE:HII) reported first quarter 2013 revenues of $1.56 billion, relatively flat compared to the same period last year.
Sign-up for Huntington Ingalls Industries Reports First Quarter Results; Segment Operating Margin Continues to Improve investment picks
2013/5/8
Idera Pharmaceuticals (NASDAQ: IDRA) today announced presentation of data from its randomized, double-blind, placebo-controlled Phase 2 trial that showed improvements from baseline of up to 90% in Psoriasis Area Severity Index (PASI) scores in patients with moderate to severe plaque psoriasis following four weeks of treatment with the Toll-like Receptor (TLR) antagonist IMO-3100.
Sign-up for Idera Announces Presentation of Positive Data from Phase 2 Trial of TLR 7 and 9 Antagonist in Patients with Moderate-to-Severe Plaque Psoriasis investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: CECO Environmental Reports First Quarter 2013 Results to Idera Announces Presentation of Positive Data from Phase 2 Trial of TLR 7 and 9 Antagonist in Patients with Moderate-to-Severe Plaque Psoriasis
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity